Navigation Links
Children living near toxic waste sites experience higher blood lead levels resulting in lower IQ
Date:5/5/2013

for Global Health at the Icahn School of Medicine at Mount Sinai, one of the authors of the study. "In order to prevent further detrimental effects on neurodevelopment in children, these countries should create programs to identify toxic wastes and reduce lead exposure."

"This study is important because, to our knowledge, the burden of disease from these toxic waste sites has never been calculated before," said Dr. Chatham-Stephens. "We are showing that children who were chronically exposed to toxic waste sites in lower and middle income countries could have had high lead blood levels."


'/>"/>

Contact: Renatt Brodsky
Renatt.Brodsky@mountsinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2

Related biology news :

1. Should we play hide-and-go-seek with our childrens vegetables?
2. New study compares diets for weight management in obese children
3. Researchers unravel genetic mechanism of fatty liver disease in obese children
4. Genetic abnormality offers diagnostic hope for childrens cancer
5. Researchers pinpoint genetic pathway of rare facial malformation in children
6. WanderID Launches Breakthrough ID Product for Children, Seniors
7. Common genetic variants identify autism risk in high risk siblings of children with ASD
8. Children exposed to the common pollutant naphthalene show signs of chromosomal damage
9. BGI and the Childrens Hospital of Philadelphia launch the 1,000 Rare Diseases Project
10. Child welfare investigation predicts mental health problems in young children
11. New book inspires children to protect dugongs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... in stride; others are done in by it. New ... of this so-called stress gap in mice with very ... researchers to better understand the development of psychiatric disorders ... animal has unique experiences as it goes through its ... alter the expression of genes, and as a result, ...
(Date:9/1/2014)... diet showed some modest improvement in the last decade ... consumption of unhealthy trans fats, but the gap in ... poor. , , An unhealthy diet is closely linked ... healthy diet is an important part of the strategy ... diet quality is important because it can offer guidance ...
(Date:9/1/2014)... It may be possible to train the brain to ... to new research by scientists at the Jean Mayer ... at Tufts University and at Massachusetts General Hospital. Published ... , a brain scan study in adult men and ... addictive power of unhealthy food while also increasing preference ...
Breaking Biology News(10 mins):Discovery hints at why stress is more devastating for some 2Discovery hints at why stress is more devastating for some 3Quality of US diet improves, gap widens for quality between rich and poor 2Quality of US diet improves, gap widens for quality between rich and poor 3Training your brain to prefer healthy foods 2
... think a city would provide a good home for bats ... buildings. But researchers at the University of Calgary made the ... for these animals. "I was really surprised," says Dr. ... biological sciences at the University of Calgary and lead author ...
... CHAMPAIGN, lll. Blood clotting is a complicated business, ... to injury. In a new study, researchers report that they ... interaction that is vital to blood clotting. This interaction ... baffled scientists for decades. The study appears ...
... State University shows that so-called biodegradable products are likely ... are releasing a powerful greenhouse gas as they break ... utensils, are broken down in landfills by microorganisms that ... a paper describing the research and professor and head ...
Cached Biology News:Big city holds empty promise for bats 2Team solves decades-old molecular mystery linked to blood clotting 2Team solves decades-old molecular mystery linked to blood clotting 3Study: Biodegradable products may be bad for the environment 2
(Date:8/31/2014)... PARSIPPANY, N.J. , Aug. 31, 2014 ... New Drug Discovery program in Anti-Infective research when two ... the coveted Qualified Infectious Disease Product (QIDP) status from ... granted to drugs which act against pathogens which have ... and are identified by Centre for Disease Control (a ...
(Date:8/29/2014)... DIEGO, Aug. 29, 2014  Pfenex Inc. (NYSE ... the development of high-value and difficult to manufacture ... update and reported financial results for the second ... the successful completion of our initial public offering, ... our biosimilar product candidates, derived from our proprietary ...
(Date:8/29/2014)... VANCOUVER , Aug. 29, 2014 /PRNewswire/ - ... (OTCQX: ICOTF), today reported financial results for the ... specified otherwise, are expressed in Canadian dollars and ... Second Quarter 2014 Highlights , ... visual acuity (VA) primary endpoint for subjects enrolled ...
(Date:8/29/2014)... 29, 2014 Intrinsic Imaging, an ... GAMP® 5 compliant imaging core lab, announced today ... II clinical trial to assess a new treatment ... trial, Intrinsic Imaging will provide comprehensive imaging core ... and charter development, site qualification, site training and ...
Breaking Biology Technology:U.S. FDA Grants QIDP Status for Wockhardt Anti-Infective Drug Discovery Program 2U.S. FDA Grants QIDP Status for Wockhardt Anti-Infective Drug Discovery Program 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 2Pfenex Reports Second Quarter 2014 Results and Provides Business Update 3Pfenex Reports Second Quarter 2014 Results and Provides Business Update 4Pfenex Reports Second Quarter 2014 Results and Provides Business Update 5Pfenex Reports Second Quarter 2014 Results and Provides Business Update 6Pfenex Reports Second Quarter 2014 Results and Provides Business Update 7Pfenex Reports Second Quarter 2014 Results and Provides Business Update 8iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4Intrinsic Imaging Awarded Phase II Clinical Trial to Assess New Treatment for Non-Hodgkin’s Lymphoma 2
... (Nasdaq: SGMO ) announced today that Philip Gregory, ... on the progress of,Sangamo,s ZFP Therapeutic development programs and ... on Wednesday, October 10, 2007,at the BIO InvestorForum in ... and may be accessed via a link on,the Sangamo ...
... Thompson, President,and CEO of Oncolytics Biotech Inc. (TSX: ... the Company at the 15th annual BioPartnering Europe,conference ... 9 a.m. The conference,will be held at the ... About Oncolytics Biotech Inc. Oncolytics is ...
... (Nasdaq: MSHL ) will present at the BIO ... Thursday, October 11, 2007 at 12:00 pm. About ... MSHL ) is a specialist oncology company,focused on the ... flavonoid technology platform which has generated a,number of novel ...
Cached Biology Technology:Sangamo BioSciences to Present at the 2007 BIO InvestorForum 2Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe 2Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 2Marshall Edwards, Inc. to Present at BIO Investor Forum 2007 3
Mouse monoclonal antibody raised against a partial recombinant CALCOCO2. NCBI Entrez Gene ID = CALCOCO2...
Mouse monoclonal to Casein Kinase 2 beta ( Abpromise for all tested applications). entrezGeneID: 1460 SwissProtID: P13862...
...
Mouse monoclonal antibody raised against a partial recombinant ZNF167. NCBI Entrez Gene ID = ZNF167...
Biology Products: